North Dakota State Investment Board Buys Shares of 5,867 HCA Healthcare, Inc. $HCA

North Dakota State Investment Board bought a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 5,867 shares of the company’s stock, valued at approximately $2,739,000.

Other hedge funds have also modified their holdings of the company. Palisade Asset Management LLC acquired a new stake in HCA Healthcare during the 3rd quarter worth approximately $26,000. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare during the 4th quarter worth approximately $29,000. Ares Financial Consulting LLC acquired a new stake in shares of HCA Healthcare in the fourth quarter valued at approximately $31,000. JPL Wealth Management LLC acquired a new stake in shares of HCA Healthcare in the third quarter valued at approximately $33,000. Finally, Aventura Private Wealth LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at $34,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts recently weighed in on HCA shares. Argus decreased their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Stephens reduced their price objective on shares of HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating for the company in a research report on Monday, April 27th. Truist Financial reduced their price objective on shares of HCA Healthcare from $546.00 to $535.00 and set a “buy” rating for the company in a research report on Monday, April 27th. The Goldman Sachs Group lifted their price objective on shares of HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Finally, UBS Group lifted their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $517.82.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 1,694 shares of the company’s stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 1.50% of the stock is owned by corporate insiders.

HCA Healthcare Stock Performance

Shares of HCA Healthcare stock opened at $422.60 on Tuesday. The firm has a 50-day moving average of $476.49 and a 200-day moving average of $485.66. The stock has a market cap of $93.75 billion, a PE ratio of 14.53, a PEG ratio of 1.34 and a beta of 1.18. HCA Healthcare, Inc. has a 52-week low of $330.00 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same period in the previous year, the firm posted $6.45 EPS. The company’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare’s dividend payout ratio is currently 10.73%.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.